Corneal collagen cross-linking using riboflavin and ultraviolet A may be considered medically necessary as a treatment of progressive keratoconus or corneal ectasia resulting from refractive surgery in patients who have failed conservative treatment (eg, spectacle correction, rigid contact lens).
Corneal collagen cross-linking using riboflavin and ultraviolet A is considered investigational for all other indications.